CP and neoplasm: In total, all procedures consisted of two main stages: 1) surgical excision of the developed orthotopic graft and 2) postsurgical therapy with cross-linking cytostatic agent CP in combination with the composite preparation of dsDNA (DNAmix), applied in accordance with preliminary determined biological parameters being specific for the tumor in question.